Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Fresh Tracks Therapeutics Inc V.BBI


Primary Symbol: FRTX

Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.


PINL:FRTX - Post by User

Post by EstevanOutsideron Jul 05, 2023 8:33pm
185 Views
Post# 35528351

boereport M&A database w/ metrics

boereport M&A database w/ metricsthis is a great tool:
https://boereport.com/ma-database/

i don't know why pipestone pulled the M&A slide last year from the presentation. it was useful for investors to see what the company could be worth based on recent montney transactions. i noticed they purged it when the company's value exceeded some of the transactions.

however, that is now out of the question as the valuation is the worst in class. using such information would show how cheap the company is using recent M&A metrics in the montney.

at $70 / $3 in a low case my projection would be $3.50-4.00 per share. at $80, $4.50-$5.00
<< Previous
Bullboard Posts
Next >>